Create a narrative

ACADIA Pharmaceuticals Community

NasdaqGS:ACAD Community

1 Narratives written by author
0 Comments on narratives written by author
53 Fair Values set on narratives written by author

Create a narrative

ACADIA Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 19 Analysts

Managed Access Programs For Trofinetide Will Begin European Market Entry In 2025

Key Takeaways Strategic initiatives, including field force expansion and marketing efforts, are set to boost U.S. market share and revenue growth in the future. Diversification strategies in Europe and a broadening pipeline highlight potential for strong, diversified future revenue streams and earnings.

US$24.47

FV

40.5% undervalued

10.67%

Revenue growth p.a.

0

0

31

1 day ago